
Sign up to save your podcasts
Or


In S3E16 of Inside the Science, we're highlighting the study, "ACL reconstruction for all is not cost-effective after acute ACL rupture" with Dr. Vincent Eggerding. He shares what else is out there in the literature on this topic, what a quality-adjusted life year is, the most important data gleaned from this study related to cost and outcomes, how many subjects in the rehab group were eventually operated on, how we might use this information clinically, and the big takeaways.
We hope to deliver this content to the committed professional who wants to improve his/her care and we hope to do it in a way that is easily accessible, the world over, in today's technological age.
To contribute:
Thanks for your support!
By Jason WardIn S3E16 of Inside the Science, we're highlighting the study, "ACL reconstruction for all is not cost-effective after acute ACL rupture" with Dr. Vincent Eggerding. He shares what else is out there in the literature on this topic, what a quality-adjusted life year is, the most important data gleaned from this study related to cost and outcomes, how many subjects in the rehab group were eventually operated on, how we might use this information clinically, and the big takeaways.
We hope to deliver this content to the committed professional who wants to improve his/her care and we hope to do it in a way that is easily accessible, the world over, in today's technological age.
To contribute:
Thanks for your support!